phosphatidylcholines has been researched along with quinine in 8 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (quinine) | Trials (quinine) | Recent Studies (post-2010) (quinine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 6,859 | 398 | 1,099 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | quinine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.28 | |
| Solute carrier family 22 member 2 | Mus musculus (house mouse) | 2.8 | |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | 3.85 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.7 | |
| Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | 0.094 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.6285 | |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | 2.0333 | |
| Cytochrome P450 2D4 | Rattus norvegicus (Norway rat) | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotterer, GS | 1 |
| Falk, M; Fürst, W | 1 |
| Hersh, L | 1 |
| Katsuragi, Y; Kurihara, K; Lee, C; Otsuji, K; Sugiura, Y | 1 |
| Katsuragi, Y; Kurihara, K; Mitsui, Y; Otsuji, K; Umeda, T; Yamasawa, S | 1 |
| Dongowski, G; Fritzsch, B; Giessler, J; Neubert, RH | 1 |
| Dongowski, G; Fritzsch, B; Giessler, J; Härtl, A; Kuhlmann, O; Neubert, RH | 1 |
| Briuglia, ML; Lamprou, DA; McFarlane, A; Rotella, C | 1 |
8 other study(ies) available for phosphatidylcholines and quinine
| Article | Year |
|---|---|
Rat liver D-beta-hydroxybutyrate dehydrogenase. 3. Inhibition by topical anesthetics.
Topics: Acetoacetates; Alcohols; Anesthetics, Local; Animals; Dibucaine; Hydroxybutyrate Dehydrogenase; Kinetics; Lipids; Liver; Mitochondria, Liver; NAD; Phosphatidylcholines; Propranolol; Quinine; Rats; Solubility; Tetracaine | 1969 |
[Drug permeation through synthetic lipid membranes. Permeability of lecithin-collodium membranes for drugs and metabolites].
Topics: Buffers; Caffeine; Diffusion; Hexobarbital; Hydrogen-Ion Concentration; Kinetics; Membranes, Artificial; Models, Chemical; Papaverine; Phenobarbital; Phenytoin; Phosphatidylcholines; Quinine; Salicylates; Solutions; Time Factors | 1974 |
The interaction of local anesthetics with lecithin monolayers.
Topics: Anesthetics, Local; Dibucaine; Ephedrine; Phosphatidylcholines; Procaine; Quinine; Surface Tension; Tetracaine | 1967 |
Selective inhibition of bitter taste of various drugs by lipoprotein.
Topics: Caffeine; Chemistry, Pharmaceutical; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Excipients; Humans; Lactoglobulins; Lipoproteins; Phosphatidic Acids; Phosphatidylcholines; Quinine; Serum Albumin, Bovine; Sodium Chloride; Sucrose; Taste; Taste Threshold; Triglycerides | 1995 |
Basic studies for the practical use of bitterness inhibitors: selective inhibition of bitterness by phospholipids.
Topics: Humans; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phospholipids; Quinine; Sodium Chloride; Solutions; Sucrose; Tartrates; Taste | 1997 |
Influence of nutrition factors forming stable mixed micelles on permeation of quinine in vitro studied by the everted sac technique.
Topics: Animals; Antimalarials; Buffers; Excipients; Glycodeoxycholic Acid; Ileum; In Vitro Techniques; Intestinal Absorption; Male; Micelles; Palmitic Acid; Phosphatidylcholines; Quinine; Rats; Rats, Wistar | 1999 |
The influence of bile salts and mixed micelles on the pharmacokinetics of quinine in rabbits.
Topics: Animals; Antimalarials; Area Under Curve; Bile Acids and Salts; Biological Availability; Duodenum; Fatty Acids; Female; Glycodeoxycholic Acid; Intubation, Gastrointestinal; Micelles; Palmitic Acid; Phosphatidylcholines; Phospholipids; Quinine; Rabbits | 2005 |
Influence of cholesterol on liposome stability and on in vitro drug release.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adrenergic beta-1 Receptor Antagonists; Antimalarials; Atenolol; Chemical Phenomena; Cholesterol; Computer Simulation; Delayed-Action Preparations; Dimyristoylphosphatidylcholine; Drug Carriers; Drug Compounding; Drug Stability; Drug Storage; Hot Temperature; Hydrophobic and Hydrophilic Interactions; Liposomes; Models, Chemical; Phosphatidylcholines; Quinine; Reproducibility of Results; Solubility | 2015 |